Press Release Covis Announces Successful Completion of Its Previously Announced Financial Recapitalization Transaction, Resulting in a Material Strengthening of Its Financial Position – Transaction supported by 100% of First Lien and 100% of Second Lien Lenders –...
Press Release Covis Statement on FDA Decision to Withdraw Approval of Makena® Zug, Switzerland, April 7, 2023 – Following the U.S. Food and Drug Administration’s decision, Covis Pharma Group (“Covis”) is effectuating the withdrawal of Makena®...
Press Release Covis Announces Signing of Support Agreements With Its Lenders and Equity Sponsors,Leading to a Material Strengthening of Its Financial Position,Including the Elimination of ~$450 Million of Debt – Support Agreement signed by approximately 95% of...
Press Release Covis Pharma Responds to Presiding Officer’s Report Summarizing FDA Advisory Committee Hearing – Company Has Requested an Orderly Wind-down in Effort to Voluntarily Withdraw Makena® Zug, Switzerland, March 07, 2023 – Covis Pharma Group (“Covis”), today...
Click here for Canada website